Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-038663

CEO and Chairman sold 33,132 shares at an average $45.85 ($1,519,227)

  • CEO and Chairman acquired 33,132 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS CHAD M CEO and Chairman 2020-06-22 Option exercise +33,132 $0.33 $10,934 1,811,312 D
ROBINS CHAD M CEO and Chairman 2020-06-22 Sale −19,629 $45.65 $896,064 1,791,683 D
ROBINS CHAD M CEO and Chairman 2020-06-22 Sale −13,503 $46.15 $623,163 1,778,180 D
Derivatives
ROBINS CHAD M CEO and Chairman 2020-06-22 Option exercise · Stock Option (Right to Buy) −33,132 348,748 D
Open-market sales · 33,132 sh · avg $45.85 · $1,519,227
Loading xslF345X03/doc4.xml…